These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19651143)

  • 1. Functional effects of a restrictive-cardiomyopathy-linked cardiac troponin I mutation (R145W) in transgenic mice.
    Wen Y; Xu Y; Wang Y; Pinto JR; Potter JD; Kerrick WG
    J Mol Biol; 2009 Oct; 392(5):1158-67. PubMed ID: 19651143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.
    Wen Y; Pinto JR; Gomes AV; Xu Y; Wang Y; Wang Y; Potter JD; Kerrick WG
    J Biol Chem; 2008 Jul; 283(29):20484-94. PubMed ID: 18430738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres.
    Dvornikov AV; Smolin N; Zhang M; Martin JL; Robia SL; de Tombe PP
    J Biol Chem; 2016 Oct; 291(41):21817-21828. PubMed ID: 27557662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development.
    Gomes AV; Liang J; Potter JD
    J Biol Chem; 2005 Sep; 280(35):30909-15. PubMed ID: 15961398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers.
    Hernandez OM; Szczesna-Cordary D; Knollmann BC; Miller T; Bell M; Zhao J; Sirenko SG; Diaz Z; Guzman G; Xu Y; Wang Y; Kerrick WG; Potter JD
    J Biol Chem; 2005 Nov; 280(44):37183-94. PubMed ID: 16115869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
    Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
    J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils.
    Kruger M; Zittrich S; Redwood C; Blaudeck N; James J; Robbins J; Pfitzer G; Stehle R
    J Physiol; 2005 Apr; 564(Pt 2):347-57. PubMed ID: 15718266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
    Kerrick WG; Kazmierczak K; Xu Y; Wang Y; Szczesna-Cordary D
    FASEB J; 2009 Mar; 23(3):855-65. PubMed ID: 18987303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients.
    Szczesna-Cordary D; Jones M; Moore JR; Watt J; Kerrick WG; Xu Y; Wang Y; Wagg C; Lopaschuk GD
    FASEB J; 2007 Dec; 21(14):3974-85. PubMed ID: 17606808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.
    Lang R; Gomes AV; Zhao J; Housmans PR; Miller T; Potter JD
    J Biol Chem; 2002 Apr; 277(14):11670-8. PubMed ID: 11801593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy.
    Davis J; Yasuda S; Palpant NJ; Martindale J; Stevenson T; Converso K; Metzger JM
    J Mol Cell Cardiol; 2012 Sep; 53(3):446-57. PubMed ID: 22683325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
    Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
    Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin.
    Gomes AV; Harada K; Potter JD
    J Mol Cell Cardiol; 2005 Nov; 39(5):754-65. PubMed ID: 16005017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac troponin mutations and restrictive cardiomyopathy.
    Parvatiyar MS; Pinto JR; Dweck D; Potter JD
    J Biomed Biotechnol; 2010; 2010():350706. PubMed ID: 20617149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin.
    Pinto JR; Parvatiyar MS; Jones MA; Liang J; Potter JD
    J Biol Chem; 2008 Jan; 283(4):2156-66. PubMed ID: 18032382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.
    Li Y; Charles PY; Nan C; Pinto JR; Wang Y; Liang J; Wu G; Tian J; Feng HZ; Potter JD; Jin JP; Huang X
    J Mol Cell Cardiol; 2010 Sep; 49(3):402-11. PubMed ID: 20580639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.
    Du J; Liu J; Feng HZ; Hossain MM; Gobara N; Zhang C; Li Y; Jean-Charles PY; Jin JP; Huang XP
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2604-13. PubMed ID: 18408133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
    Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
    Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.
    Burton D; Abdulrazzak H; Knott A; Elliott K; Redwood C; Watkins H; Marston S; Ashley C
    Biochem J; 2002 Mar; 362(Pt 2):443-51. PubMed ID: 11853553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional consequences of the mutations in human cardiac troponin I gene found in familial hypertrophic cardiomyopathy.
    Takahashi-Yanaga F; Morimoto S; Harada K; Minakami R; Shiraishi F; Ohta M; Lu QW; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2001 Dec; 33(12):2095-107. PubMed ID: 11735257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.